Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Zheng M. Classification and pathology of lung cancer. Surg Oncol Clin N Am. 2016;25:447–68.
2. Wang X, Zhang Y, Hu M, Wang R, Liu L, Qian K, et al. Prognostic and predictive value of thyroid transcription factor-1, CD56, p40 and other clinical characteristics in small cell lung cancer patients. Chin J Lung Cancer. 2017;20:522–7.
3. Gkika E, Benndorf M, Oerther B, Mohammad F, Beitinger S, Adebahr S, et al. Immunohistochemistry and radiomic features for survival prediction in small cell lung cancer. Front Oncol. 2020;10:1161.
4. Wang JY, Wang XM, Xu XY, Li SR, Liu XL. Expression and Significance of CK5/6, P63, P40, CK7, TTF-1, NapsinA, CD56, Syn and CgA in biopsy specimen of squamous cell carcinoma, adenocarcinoma and small cell lung carcinoma. Int J Morphol. 2020;38:247–51.
5. Yakovtsova I, Yanchevskiy O, Chertenko T, Kis A, Oliyinyk A. Immunohistochemical diagnosis and prognosis of small cell lung cancer: the search for new strategies. ScienceRise: Med Sci 2022;1(46):31–36